A Welsh health board has come under intense scrutiny after a hospital patient died from a morphine overdose just two days after being mistakenly prescribed the powerful opioid medication upon discharge. The Public Services Ombudsman for Wales has described the incident as an “extremely serious injustice,” concluding that a series of failures by medical and pharmacy staff contributed to circumstances that significantly increased the risk of a fatal overdose.
The case has reignited concerns about patient safety, medication management, and clinical oversight within hospitals, while highlighting the potentially devastating consequences of prescription errors involving high-risk drugs such as opioids.
According to the ombudsman’s report, the patient, referred to only as Mr P, had been admitted to Wrexham Maelor Hospital in March 2024 for treatment related to alcohol withdrawal symptoms. During his hospital stay, he was administered Sevredol, a morphine sulphate medication commonly used to manage severe pain. However, investigators found that a critical error occurred when arrangements were being made for his discharge.
The doctor responsible for discharging Mr P mistakenly believed that he had been taking morphine prior to his hospital admission. As a result, the patient was prescribed additional morphine sulphate medication to take home, despite there being no clinical justification for continuing the opioid treatment after discharge.
The ombudsman’s investigation found that the prescribing mistake should have been identified through routine safeguards. However, multiple opportunities to detect and correct the error were missed. Medical personnel and pharmacy staff failed to conduct the expected verification checks that form part of standard prescribing and dispensing procedures.
As a consequence, Mr P left hospital with a supply of morphine that investigators concluded he should never have received.
Tragically, two days after returning home, Mr P died from a morphine overdose. A subsequent coroner’s inquest determined that his death resulted from misadventure, a legal conclusion used when a fatality occurs due to unintended consequences rather than deliberate actions.
Although investigators could not definitively establish that the medication supplied by the hospital directly caused Mr P’s death, the ombudsman concluded that the erroneous prescription significantly increased the likelihood of accidental overdose.
The report emphasized that opioid medications carry substantial risks, particularly when prescribed without adequate clinical assessment, patient education, or monitoring. Official guidance on opioid prescribing requires healthcare professionals to provide clear information regarding the dangers of tolerance, dependency, and accidental overdose. Investigators found that Mr P was not given appropriate advice about these risks before leaving hospital.
The absence of such guidance represented another serious failure in the patient’s care pathway.
For Mr P’s widow, the findings have intensified feelings of frustration and betrayal. She stated that she felt completely let down by the healthcare professionals responsible for her husband’s care, describing the situation as one in which he was effectively discharged from hospital carrying a potentially lethal risk without understanding the danger involved.
Her comments underscore the emotional toll the tragedy has taken on the family and highlight broader concerns about trust in healthcare systems when avoidable clinical mistakes occur.
Public Services Ombudsman for Wales Michelle Morris described the circumstances surrounding the case as deeply troubling. She stated that the failures identified throughout the investigation should have been detected and addressed much earlier.
Morris noted that the combination of incorrect prescribing, inadequate verification processes, and insufficient patient information created conditions that ultimately exposed Mr P to unacceptable levels of risk.
The ombudsman’s report concluded that both the patient and his family experienced a profound injustice as a result of the failures. In response, the report recommended that the health board issue a formal apology to Mr P’s widow and provide financial compensation of £2,000 in recognition of the distress and injustice caused.
The recommendations also require the health board to undertake a comprehensive review of prescribing and pharmacy procedures within six months. The review is expected to examine existing safeguards, identify weaknesses in medication management processes, and introduce measures aimed at preventing similar incidents in the future.
Betsi Cadwaladr University Health Board has acknowledged the findings of the investigation and accepted responsibility for the shortcomings identified.
Chris Lynes, Deputy Executive Director of Nursing for the health board, admitted that the care provided fell below the standards patients and families have a right to expect. He confirmed that a direct letter of apology would be sent to Mr P’s family and pledged that lessons arising from the investigation would be fully implemented.
The health board also addressed criticism regarding its handling of the family’s complaint following the incident. Investigators raised concerns about aspects of the complaint process, prompting renewed commitments from the organisation to strengthen transparency and accountability.
Lynes reiterated the board’s commitment to the Duty of Candour, a principle requiring healthcare providers to be open and honest with patients and families when things go wrong. He stated that the organisation would continue addressing the concerns highlighted by the ombudsman while implementing necessary improvements across its clinical and pharmacy services.
The case has drawn wider attention to medication safety within healthcare settings, particularly regarding opioid prescribing practices. Across the UK, healthcare regulators have repeatedly stressed the importance of robust prescribing safeguards, comprehensive medication reviews, and effective communication with patients receiving high-risk medicines.
Experts note that opioid medications remain an essential component of pain management for many patients. However, they also carry well-documented risks of overdose, dependency, and serious adverse outcomes when prescribed or used incorrectly.
The tragic death of Mr P serves as a stark reminder of the critical importance of rigorous clinical checks at every stage of the prescribing and discharge process. As healthcare providers continue to strengthen patient safety systems, the findings of this investigation are likely to influence future reviews of prescribing practices, pharmacy oversight, and discharge procedures across hospitals in Wales and beyond.
For Mr P’s family, however, the focus remains on ensuring that lessons are learned so that no other family experiences a similar loss caused by preventable failures in healthcare delivery.